ArticleCancers2022

Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Liangcun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.